We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-1.32%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$493M
AUM Growth
-$43.7M
(-8.1%)
Cap. Flow
-$6.65M
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
14.21%
Holding
1,115
New
370
Increased
135
Reduced
155
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.8M |
| 2 |
Micron Technology
MU
|
+$9.79M |
| 3 |
Medtronic
MDT
|
+$7.24M |
| 4 |
Meta Platforms (Facebook)
META
|
+$6.64M |
| 5 |
Alibaba
BABA
|
+$5.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Truist Financial
TFC
|
+$6.76M |
| 2 |
Qualcomm
QCOM
|
+$6.11M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.04M |
| 4 |
EOG Resources
EOG
|
+$4.02M |
| 5 |
T-Mobile US
TMUS
|
+$3.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 13.66% |
| 3 | Consumer Discretionary | 12.3% |
| 4 | Industrials | 9.83% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Novavax
NVAX
$1.23B
| – | – |
-15,374
| Closed | -$791K |
|
927
NovoCure
NVCR
$1.97B
| – | – |
-4,850
| Closed | -$337K |
|
928
New York Times
NYT
$11.7B
| – | – |
-13,800
| Closed | -$385K |
|
929
Ocular Therapeutix
OCUL
$1.89B
| – | – |
-16,200
| Closed | -$65K |
|
|
OGI
930
Organigram Holdings
OGI
$132M
| – | – |
-16,575
| Closed | -$61K |
|
931
Organon & Co
OGN
$3.56B
| – | – |
-54,415
| Closed | -$1.84M |
|
932
Omega Healthcare
OHI
$15.3B
| – | – |
-14,500
| Closed | -$409K |
|
933
Okta
OKTA
$23.9B
| – | – |
-15,274
| Closed | -$1.38M |
|
934
Ollie's Bargain Outlet
OLLI
$4.04B
| – | – |
-4,092
| Closed | -$240K |
|
935
OneMain Financial
OMF
$7.08B
| – | – |
-8,978
| Closed | -$336K |
|
|
ACH
936
Accendra Health
ACH
$247M
| – | – |
-19,600
| Closed | -$616K |
|
937
ON Semiconductor
ON
$34.7B
| – | – |
-36,600
| Closed | -$1.84M |
|
938
Opendoor
OPEN
$3.71B
| – | – |
-73,785
| Closed | -$336K |
|
939
Opko Health
OPK
$936M
| – | – |
-33,700
| Closed | -$85K |
|
940
Oracle
ORCL
$345B
| – | – |
-38,100
| Closed | -$2.66M |
|
941
Bank OZK
OZK
$5.5B
| – | – |
-7,871
| Closed | -$295K |
|
942
Pan American Silver
PAAS
$18.6B
| – | – |
-12,566
| Closed | -$247K |
|
943
Patrick Industries
PATK
$2.81B
| – | – |
-14,249
| Closed | -$492K |
|
944
Payoneer
PAYO
$2.41B
| – | – |
-58,800
| Closed | -$230K |
|
945
PBF Energy
PBF
$7.43B
| – | – |
-8,296
| Closed | -$241K |
|
946
Prestige Consumer Healthcare
PBH
$2.39B
| – | – |
-4,918
| Closed | -$289K |
|
947
Procore
PCOR
$7.03B
| – | – |
-9,000
| Closed | -$409K |
|
948
PagerDuty
PD
$753M
| – | – |
-8,700
| Closed | -$216K |
|
949
Pfizer
PFE
$141B
| – | – |
-18,400
| Closed | -$965K |
|
950
Performance Food Group
PFGC
$18B
| – | – |
-7,200
| Closed | -$331K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Bayesian Capital Management held 1,115 positions worth $493M, down 8.1% from $537M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bayesian Capital Management's Q3 2022 filing shows 370 new, 135 increased, 155 reduced and 453 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M. The largest sale was Truist Financial, an estimated $6.76M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M.
- Bayesian Capital Management added most to Medtronic in Q3 2022, an estimated $7.24M increase.
- Bayesian Capital Management's biggest Q3 2022 reduction was Truist Financial, cutting an estimated $6.76M.
- Bayesian Capital Management fully exited Walgreens Boots Alliance in Q3 2022, selling an estimated $4.04M.
- Bayesian Capital Management's ten largest holdings make up 14% of its $493M portfolio in Q3 2022.
- Bayesian Capital Management opened 370 new positions and closed 453 in Q3 2022.
- Bayesian Capital Management's portfolio value fell 8.1% quarter-over-quarter to $493M.
Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.